Perspectives & Progress

The Final Frontier of Drug Delivery: Navigating the Blood-Brain Barrier

The next generation of CNS therapies will depend on crossing the blood-brain barrier safely, selectively, and at therapeutic scale.

Jonathan Bush: Why Healthcare Needs More Rule Breakers

Jonathan Bush, CEO of Zus Health, shares his vision on how artificial intelligence can transform healthcare by automating administrative tasks and why disruptive innovation is crucial in the sector.

Newsweek Recognizes Recuro Health as One of the World’s Best Digital Health Companies in 2024

Digital-first healthcare provider honored by Newsweek and Statista as a top innovator in virtual primary, urgent, behavioral care, genomics, and at-home testing—solidifying its leadership in telehealth.

Recuro Health Closes $47 Million Series B Financing Led by ARCH  Venture  Partners, Advancing Virtual‑First Care

Recuro Health, a Dallas-based digital health startup, raised $47 M to scale its Digital Medical Home—including virtual primary & behavioral care, at-home diagnostics, and genomics—with support from ARCH Venture Partners and others.

Zus Health Closes Financing, Signs Partnership with Elation Health to Accelerate Growth of Its Data Service

Health‑IT platform ‘connecting the connective tissue for healthcare’ closes a $40 M financing round and partners with Elation Health to integrate its ZAP aggregated patient profile into primary‑care EHR workflows.

They said I should give up, but I don’t like to give up”: How Robert Langer failed repeatedly—and kept going

A trailblazing MIT professor and co‑founder of Moderna who pioneered nanoparticle delivery of nucleic acids. Despite early skepticism and patent rejections, his persistence led to breakthroughs foundational for mRNA vaccines.

Ready to Transform Healthcare?

Join us in building the future of medicine through innovative technology and biology convergence